| Zurich Market Talk - 05-01-2012 |
| 05.01.12 01:20 | |
|
Newron Pharmaceuticals S.p.A. (“Newron”), a research and development company focused on novel CNS and pain therapies, announced today it has agreed with Meiji Seika Pharma Co., Ltd. (“Meiji”), a subsidiary of the Meiji Holdings Co., Ltd., Tokyo, Japan, on the principal terms and conditions of a license transaction covering the research, development, manufacturing, and marketing of safinamide in Japan and key Asian territories. Link: Click Here Basilea Pharmaceutica Ltd. (SIX:BSLN) today announced that it will apply in the second half of 2012 for approval of its antibiotic ceftobiprole in Europe. In addition, reporting of topline data for the alitretinoin U.S. phase III study for chronic refractory hand eczema will occur in the first quarter of this year. Basilea thus has the potential for two regulatory submissions in 2012. Link: Click Here AFG invests CHF 30 million in expansion of RWD Schlatter AG. Over the next five years AFG Arbonia-Forster-Holding AG is to invest CHF 30 million in the expansion of RWD Schlatter AG, based at Roggwil/Thurgau, which will also result in the creation of 40 new jobs. This investment is a clear recognition of the importance to AFG of its subsidiary RWD Schlatter AG and of Switzerland as a production location. Link: Click Here Ascom Network Testing enhances its position in the Reporting & Analysis market segment. Ascom Network Testing acquires all relevant assets of Veelong Corp. based in Fanwood NJ (USA). Veelong develops discerning solutions for post-processing and analysis of mobile network testing data. This acquisition further strengthens the current position of Ascom Network Testing in the Reporting & Analysis market segment. Link: Click Here Myriad Group AG (SIX: MYRN), the company powering billions of rich mobile social and web experiences on any connected device, and Broadcom Corporation (NASDAQ: BRCM), a global leader in semiconductor solutions for wired and wireless communications today announced a joint effort to drive the Android ecosystem to televisions. Link: Click Here BKW: Mühleberg Nuclear Power Plant - Impressive electricity output despite lengthy revision. In 2011 the Mühleberg power plant (KKM) of BKW Inc. generated 2,605 million Kilowatt hours (kWh) of electricity: 16% less than in 2010 (3,109 million kWh). The reduction is due to the extended revision of the plant in the summer of 2011. Link: Click Here Economy ******** SNB: New information underscores Hildebrands innocence. Below are the most important transactions executed on behalf of the account of Mr Hildebrand in 2011. The transaction data proves that on August 15th, an unrealized loss amounting to over USD 150'000 had been incurred. The subsequent purchase led the average price to drop to 0,8940 from 0,9375. USDCHF was trading at 0,7929 and an intervention and its possible effect highly in doubt. Link: Click Here UK lending to individuals remains subdued. Bank of England (BoE) lending data showed consumer credit was stronger than expected while mortgage lending was weaker than expected. Net consumer credit was £0.4bn in November from £0.1bn previously (consensus: £0.2bn, BarCap: £0.1bn), with the increase driven primarily by a rise in other loans and advances, while credit card lending was broadly unchanged. Link: Click Here The UK construction PMI increased to 53.2 in December, from 52.3, ahead of our and the consensus forecast of 51.5. At this level the index is consistent with reasonably positive growth. Furthermore, growth appears to be broadly-based: all three subcomponents - housing, commercial and civil engineering - reported positive growth, the first time since March 2011 that the sector has seen such a broad-based expansion. Link: Click Here |
| < Prev | Next > |
|---|